(Q71804733)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

essential hypertension

1 reference

S Oparil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Dyke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

F Harris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J Kief

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

D James

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Hester

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Fitzsimmons

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

797-810

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Antihypertensive therapy in the era of evidence based medical practice: what to do until the facts are in

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Refractory hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

RANDOMISED CLINICAL TRIAL OF STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE IN PRIMARY HYPERTENSION

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Angiotensin receptor antagonists: focus on losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Cough associated with angiotensin converting enzyme inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. The OCAPI Study Group. Optimiser le Choix d'un Anti-hypert

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980040-3

7 January 2021

10.1016/S0149-2918(96)80040-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930424%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference